NCT02465476View on ClinicalTrials.gov

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

NACompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

January 6, 2015

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Skin Disease
Interventions
PROCEDURE

telemedicine

treatment pathway organized by telemedicine

Trial Locations (1)

31059

UHToulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02465476 - Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine | Biotech Hunter | Biotech Hunter